Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2026 is -30.69% vs 95.10% in Mar 2025
Other Long Term Liabilities
YoY Growth in year ended Mar 2026 is 44.00% vs 47.06% in Mar 2025
Fixed Assets
YoY Growth in year ended Mar 2026 is 179.80% vs 57.14% in Mar 2025
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2026 is 78.52% vs 137.26% in Mar 2025
Compare Balance Sheet Results of Aptus Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
6.86
34.94
-28.08
-80.37%
Share Warrants & Outstandings
Total Reserve
16.49
108.53
-92.04
-84.81%
Shareholder's Funds
23.35
144.45
-121.10
-83.84%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.52
147.15
-146.63
-99.65%
Secured Loans
0.00
147.15
-147.15
-100.00%
Unsecured Loans
0.52
0.00
0.52
0.00%
Deferred Tax Assets / Liabilities
-0.09
-14.20
14.11
99.37%
Other Long Term Liabilities
0.36
4.59
-4.23
-92.16%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
20.44
-20.44
-100.00%
Total Non-Current Liabilities
0.79
157.98
-157.19
-99.50%
Current Liabilities
Trade Payables
8.15
107.25
-99.10
-92.40%
Other Current Liabilities
4.49
20.76
-16.27
-78.37%
Short Term Borrowings
6.66
68.30
-61.64
-90.25%
Short Term Provisions
0.00
4.73
-4.73
-100.00%
Total Current Liabilities
19.31
201.04
-181.73
-90.39%
Total Liabilities
43.44
503.47
-460.03
-91.37%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
4.04
304.98
-300.94
-98.68%
Less: Accumulated Depreciation
1.28
92.01
-90.73
-98.61%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
2.77
212.97
-210.20
-98.70%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
25.42
-25.42
-100.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
0.03
-0.03
-100.00%
Long Term Loans & Advances
0.00
9.56
-9.56
-100.00%
Other Non Current Assets
5.44
0.68
4.76
700.00%
Total Non-Current Assets
8.21
264.91
-256.70
-96.90%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
13.57
50.63
-37.06
-73.20%
Sundry Debtors
18.76
143.28
-124.52
-86.91%
Cash and Bank
1.03
7.63
-6.60
-86.50%
Other Current Assets
0.09
24.47
-24.38
-99.63%
Short Term Loans and Advances
1.79
12.55
-10.76
-85.74%
Total Current Assets
35.24
238.56
-203.32
-85.23%
Net Current Assets (Including Current Investments)
15.93
37.52
-21.59
-57.54%
Total Current Assets Excluding Current Investments
35.24
238.56
-203.32
-85.23%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
43.44
503.47
-460.03
-91.37%
Contingent Liabilities
0.00
122.80
-122.80
-100.00%
Total Debt
7.18
215.45
-208.27
-96.67%
Book Value per share (adjusted)
13.61
41.34
-27.73
-67.08%
Annual - Borrowings
Borrowings 7.18 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -30.69% vs 95.10% in Mar 2025
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.36 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 44.00% vs 47.06% in Mar 2025
Annual - Fixed Assets
Fixed Assets 2.77 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 179.80% vs 57.14% in Mar 2025
Annual - Investments
Investments 0.00 Cr
in Mar 2026Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 35.24 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 78.52% vs 137.26% in Mar 2025
